To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT05405439 · TERMINATED
Trial details
- NCT number
- NCT05405439
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2023-07-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.